- Home
- HPI vs ORGO Comparison
HPI vs ORGO Comparison
Compare HPI & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HPI
- ORGO
- Stock Information
- Founded
- HPI 2002
- ORGO 1985
- Country
- HPI United States
- ORGO United States
- Employees
- HPI N/A
- ORGO N/A
- Industry
- HPI Trusts Except Educational Religious and Charitable
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- HPI Finance
- ORGO Health Care
- Exchange
- HPI Nasdaq
- ORGO Nasdaq
- Market Cap
- HPI 459.4M
- ORGO 459.5M
- IPO Year
- HPI N/A
- ORGO N/A
- Fundamental
- Price
- HPI $17.26
- ORGO $3.21
- Analyst Decision
- HPI
- ORGO Strong Buy
- Analyst Count
- HPI 0
- ORGO 2
- Target Price
- HPI N/A
- ORGO $5.00
- AVG Volume (30 Days)
- HPI 64.7K
- ORGO 387.6K
- Earning Date
- HPI 01-01-0001
- ORGO 02-27-2025
- Dividend Yield
- HPI 8.97%
- ORGO N/A
- EPS Growth
- HPI N/A
- ORGO N/A
- EPS
- HPI N/A
- ORGO N/A
- Revenue
- HPI N/A
- ORGO $455,038,000.00
- Revenue This Year
- HPI N/A
- ORGO $9.65
- Revenue Next Year
- HPI N/A
- ORGO $1.57
- P/E Ratio
- HPI N/A
- ORGO N/A
- Revenue Growth
- HPI N/A
- ORGO 1.34
- 52 Week Low
- HPI $12.85
- ORGO $2.17
- 52 Week High
- HPI $16.83
- ORGO $4.57
- Technical
- Relative Strength Index (RSI)
- HPI 47.57
- ORGO 38.78
- Support Level
- HPI $17.42
- ORGO $3.42
- Resistance Level
- HPI $17.78
- ORGO $3.78
- Average True Range (ATR)
- HPI 0.21
- ORGO 0.15
- MACD
- HPI -0.04
- ORGO -0.04
- Stochastic Oscillator
- HPI 23.53
- ORGO 1.72
About HPI John Hancock Preferred Income Fund of Beneficial Interest
John Hancock Preferred Income Fund is a closed-end, diversified management investment company. Its primary investment objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. It seeks to achieve its investment objectives by investing in securities that may be undervalued relative to similar securities in the marketplace. The fund's principal investment strategies include investing a majority of its assets in preferred stocks and other preferred securities. Its portfolio composition consists of U.S preferred securities, common stocks, foreign preferred securities, corporate bonds, and short-term investments.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.